• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种支气管解痉气雾剂组合的临床经验。

Clinical experience with a bronchospasmolytic aerosol combination.

作者信息

Forche G, Harnoncourt K

出版信息

Z Erkr Atmungsorgane. 1986;166(1):47-52.

PMID:2937212
Abstract

A comparative study with different bronchospasmolytic inhalers (fenoterol, ipratropium bromide, combination IK-6) was done with ten patients with obstructive airway disease. After a delayed initial effect (owing to the propellant gas) ipratropium bromide showed a bronchospasmolytic effect as good as fenoterol, but without circulatory side effects. The combination with low dosed fenoterol (Berodual) produced equally good subjective and objective results with less side effects than the high dosed fenoterol. These results should form the basis for an optimal long term treatment.

摘要

对10名患有阻塞性气道疾病的患者使用不同的支气管解痉吸入剂(非诺特罗、异丙托溴铵、IK-6组合)进行了一项对比研究。在出现延迟的初始效应(由于推进剂气体)后,异丙托溴铵显示出与非诺特罗一样好的支气管解痉效果,但没有循环系统副作用。低剂量非诺特罗组合(备劳得)产生了同样良好的主观和客观效果,且副作用比高剂量非诺特罗少。这些结果应成为优化长期治疗的基础。

相似文献

1
Clinical experience with a bronchospasmolytic aerosol combination.一种支气管解痉气雾剂组合的临床经验。
Z Erkr Atmungsorgane. 1986;166(1):47-52.
2
[Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].[与沙丁胺醇相比,非诺特罗-异丙托溴铵联合气雾剂单次给药效果的对照临床研究]
Arch Monaldi. 1983 Sep-Dec;38(5-6):241-54.
3
[Basic medication of chronic obstructive lung disease with berodual].
Klin Med (Mosk). 1999;77(7):47-8.
4
Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease.
Respiration. 1986;50 Suppl 2:280-4. doi: 10.1159/000195146.
5
Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.一种新型含氢氟烷烃134a的定量吸入器与传统含氯氟烃吸入器(贝罗都尔)用于递送非诺特罗/异丙托溴铵固定组合的治疗等效性。一项针对哮喘患者的随机双盲安慰剂对照交叉研究。
Respiration. 1997;64(4):273-80. doi: 10.1159/000196686.
6
[Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].新型定量吸入器IK-6(支气管扩张剂非诺特罗与异丙托溴铵的复方制剂)的临床药理试验(作者译)
Wien Med Wochenschr. 1980 Jun 15;130(11):385-93.
7
[Berodual: clinical experience].[倍氯米松气雾剂:临床经验]
Klin Med (Mosk). 1999;77(6):46-7.
8
Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
Respiration. 1986;50 Suppl 2:165-8. doi: 10.1159/000195119.
9
A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.吸入非诺特罗与异丙托溴铵复方制剂(多索茶碱)与吸入非诺特罗和沙丁胺醇的效果比较。
Postgrad Med J. 1984;60 Suppl 1:24-7.
10
The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease.抗胆碱能药物与拟交感神经药物吸入对重度慢性阻塞性肺疾病患者的互补作用。
Acta Tuberc Pneumol Belg. 1976 May-Aug;67(3-4):163-73.